Newsroom.

AusBiotech, Australia’s leading national industry association representing more than 3000 members across the life sciences sector and BioMelbourne Network, Victoria’s leading industry association for organisations engaged in biotechnology, medical technology, and health innovation, have announced the signing of a Memorandum of Understanding (MOU) to promote stronger collaboration between both organisations.

The MOU marks a significant milestone as the organisations work to support the state and national growth agenda for the life sciences ecosystem. It recognises the opportunity that greater industry collaboration offers, as a key to unlocking the sector's full potential.

Under the terms of the MOU, AusBiotech and BioMelbourne Network will further their collaboration across the key areas of member connection, knowledge sharing and sector advocacy.

Rebekah Cassidy, CEO of AusBiotech, stated:

“I couldn’t be more delighted to formalise AusBiotech’s relationship with BioMelbourne Network. Both of our organisations have a proud history of advocating on behalf of our members and share common goals when it comes to furthering the opportunities for life sciences sector growth.

“The combined pressures of a changing world, including pandemics, supply chain stress, aging populations, climate change and geopolitical tension mean that Australia’s capacity to strategically build on its health and medical research strengths, by growing and retaining a thriving commercialised biotech and medtech sector, has never been more important.

These factors bring into sharp focus the need for all parts of our industry to collaborate and build cohesive voice that furthers Australia’s on shore biotechnology development and commercialisation capability. The signing of this MOU is an important step toward that.

Karen Parr, CEO of BioMelbourne Network, commented:

“This MOU represents more than just an agreement; it’s a commitment between BioMelbourne Network and AusBiotech for greater collaboration as we drive a shared vision for our sector’s healthy and robust future.”

“As the voice of Victoria's growing and thriving health tech sector, it’s critical that the depth of experience present in this state supports the national discussion, and that vice versa, so that together we create new opportunities and insights that strengthens the innovation present.

“Our organisations are dedicated to advocating for our members, and a united industry will elevate and build a sector that benefits from our shared success.”

About AusBiotech:

AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3000 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members’ growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies.

About BioMelbourne Network:

BioMelbourne Network is a peak body representing the healthtech industry in Melbourne. Since 2001, it has been actively fostering and growing an innovative, globally-competitive sector, and transforming its Network as well as the broader Victorian ecosystem. With more than 6,000 members, BioMelbourne Network focuses on building an engaged and collaborative healthtech community through data and insights, promotes and advocates for sector growth, and provides members with opportunities to accelerate innovation.

-ENDS-

Media enquiries: Emma Boscheinen, Director of Communications, AusBiotech, eboscheinen@ausbiotech.org / M: +61 (0) 437 075 209

Media enquiries: Karen Parr, CEO, BioMelbourne Network, kparr@biomelbourne.org / M +61 (0) 420 729 123